Within the past decade, CRISPR/Cas9 gene editing of mammalian cells has become common practice, but does it hold the key to unlocking future of therapeutic development? Join Dr. David Fischer and our panel for a detailed look at the advantages and applications of this Nobel Prize-winning technology.   Acknowledgements: Hosted by: Gina MullaneNarrated by: Chris Garcia  Special thanks to:  Dr. David Fischer

Within the past decade, CRISPR/Cas9 gene editing of mammalian cells has become common practice, but does it hold the key to unlocking future of therapeutic development? Join Dr. David Fischer and our panel for a detailed look at the advantages and applications of this Nobel Prize-winning technology. Acknowledgements: Hosted by: Gina Mullane Narrated by: Chris Garcia Special thanks to: Dr. David Fischer

Within the past decade, CRISPR/Cas9 gene editing of mammalian cells has become common practice, but does it hold the key to unlocking future of therapeutic development? Join Dr. David Fischer and our panel for a detailed look at the advantages and applications of this Nobel Prize-winning technology.&nbsp; &nbsp;Acknowledgements:&nbsp;Hosted by: Gina MullaneNarrated by: Chris Garcia&nbsp;&nbsp;Special thanks to: &nbsp;Dr. David Fischer

Driving Drug Development with CRISPR/Cas9

Life science is complicated, but its mission is simple – to create a safer, healthier future. This podcast tells the stories behind the science from the perspective of patients, scientists, employees, and advocates that have felt its impact.

Share Driving Drug Development with CRISPR/Cas9

Sign up to save your podcasts

Driving Drug Development with CRISPR/Cas9

Driving Drug Development with CRISPR/Cas9